24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Depression: Depression & Related Conditions
Resources
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Impaired White Matter Integrity for Depression in Parkinson'sHealth Tip: Fight Seasonal Affective DisorderNetwork Density Not Linked to Response in Teen DepressionSimple ECG May Help Distinguish MDD From Bipolar DepressionTreatment Trajectories Vary for Children With DepressionIf Dad Has Depression, Kids Might Develop It, TooPsychedelic Amazonian Drug Might Ease Symptoms of Depression, AlcoholismHelp for Seasonal DepressionOnline CBT Program Beneficial for Depression, AnxietyLocus ID'd That Links Comorbid Alcohol Dependence, DepressionSummer Baby, Higher Odds for Postpartum Depression?More Evidence That Depression Shortens LivesRegular Leisure-Time Exercise May Cut Incidence of DepressionMoving Just 1 Hour a Week May Curb Depression RiskHealth Tip: Do You Need Psychological Therapy?Psychosocial Intervention Ups Adherence to AntidepressantsPostpartum Depression Likely to Recur With Future PregnanciesCancer Patients May Have Undiagnosed DepressionMom-to-Be's Antidepressants Tied to Kids' Psychiatric WoesToo Many New Mothers Silent on Postpartum Depression1 in 5 Moms Mum About Post-Pregnancy BluesGoogle Search for 'Depression' Now to Provide Screening TestAre Depressed Teens Prone to Violence?Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.U.S. Antidepressant Use Jumps 65 Percent in 15 YearsSmoking During Pregnancy Up Among Women With DepressionDepression After Coronary Artery Disease Diagnosis Ups Death RiskYoga May Help Ease DepressionToo Soon to Widely Recommend Ketamine for DepressionLonger Estrogen Exposure May Protect Against DepressionEstrogen May Influence Women's Depression RiskLosing Medicaid Tough on People Battling Depression: StudyLink for Maternal Antidepressant, Kids' Brain Health QuestionedAddition of Aripiprazole Ups Major Depressive Disorder RemissionNo Sign That Antidepressants in Pregnancy Harm Kids' Brains: StudyMed Switch Not Always Best Choice With Tough DepressionDepression Contributes to Health Decline Seen in Cancer CaregiversDepression May Worsen Health for Cancer CaregiversElectric Brain Stimulation No Better Than Meds For Depression: StudyDepression Inversely Linked to Body Composition in TeensReview: Depression Screening As Inpatient Important, FeasibleDepression Can Slow Hospital Patients' Recovery: StudyAntidepressants During Pregnancy Safe for Baby: StudyChronic Pain Common in Adults With Depression, AnxietyWhat You Need to Know About AntidepressantsAPA: Internet-Based CBT Can Be Helpful in DepressionCan Online Treatment Replace Your Therapist?Depression Often a Precursor to Falls in Elderly PeopleOverweight in Childhood May Up Lifetime Risk of DepressionHeavy Kids Face Triple the Odds for Depression in Adulthood
Questions and AnswersLinks
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

Blood Test Promising for ID of Early Depression, Schizophrenia


HealthDay News
Updated: Mar 15th 2017

new article illustration

WEDNESDAY, March 15, 2017 (HealthDay News) -- The first objective, physiological marker for two major psychiatric disorders has been developed, according to a study published online March 13 in Experimental Physiology.

Handan Gunduz-Bruce, M.D., of the Yale School of Medicine in New Haven, Conn., and colleagues note that animal research had already shown that the release of arginine-vasopressin (AVP) relies on N-methyl-D-aspartate (NMDA) receptor signaling. NMDA receptor signaling appears to be increased in patients with depression but reduced in those with schizophrenia, the study authors explained.

The research team used hypertonic saline to induce the release of AVP. Each patient's blood was then tested for AVP. The investigators found that depressed patients had a greater release of the hormone, while patients with schizophrenia had a decreased production.

"This is the first objective, physiological marker for two major psychiatric disorders that, once fully developed into a clinical test, can allow for earlier and more accurate diagnosis, and selection of more appropriate medications for patients," Gunduz-Bruce said in a news release from The Physiological Society.

Gunduz-Bruce is the inventor of this technology and has submitted a patent based on the methodology.

Abstract
Full Text